However, no correlation was found between IGF2BP3 protein levels and other clinicopathological parameters, such as age, sex, clinical T classification, clinical N classification, clinical stage and recurrence after initial treatment in NPC patients (Table S3). The gene discussed is IGF2BP3; the disease is nasopharyngeal carcinoma.